SCHEMBL17953704

SCHEMBL17953704

c1ccc(-n2c3ccccc3c3cc(-c4ccc5sc6ccc(-c7ccc8c(c7)-c7cccc9cccc-8c79)cc6c5c4)ccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.40
ATM Q13315 3/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 3/20 0.34
TSHR P16473 3/20 0.34
MAPK1 P28482 3/20 0.34
HSD17B10 Q99714 3/20 0.34
HPGD P15428 2/20 0.34
CASP1 P29466 2/20 0.34
HIF1A Q16665 2/20 0.34
TP53 P04637 1/20 0.34
CASP7 P55210 1/20 0.34
PTGER4 P35408 1/20 0.32
TSPO P30536 1/20 0.31
PDE10A Q9Y233 1/20 0.31
MEN1 O00255 1/20 0.31
APAF1 O14727 1/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17953841 0.96 L3MBTL1 (0.34) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL17953711 0.94 L3MBTL1 (0.39) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL24363183 0.93 ATM (0.36) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL18252587 0.92 L3MBTL1 (0.47) L3MBTL1ATMKDM4EALDH1A1HSD17B10
SCHEMBL17953664 0.92 L3MBTL1 (0.47) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL17953706 0.91 L3MBTL1 (0.35) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL17953799 0.91 ALDH1A1 (0.33) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL17953725 0.91 L3MBTL1 (0.46) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL17953719 0.91 L3MBTL1 (0.46) L3MBTL1ATMKDM4EALDH1A1TSHR
SCHEMBL18252543 0.90 L3MBTL1 (0.45) L3MBTL1ATMKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10622569-B2 Compound, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-04-14 US disclosed
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-07-28 US disclosed
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160218299-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE EFNA1, L1CAM, LEF1 L3MBTL1 1706/4885ATM 3520/4885KDM4E 2030/4885
US-10622569-B2 Compound, organic electroluminescent element, and electronic device EFNA1, L1CAM, LEF1 L3MBTL1 1706/4885ATM 3520/4885KDM4E 2030/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.